Withdrawal Notice

This paper was originally published in Aging Advance Online Publications on November 29, 2020.

In compliance with Aging's withdrawal policy, the paper was withdrawn in its entirety. It will not appear in Aging internal or any external indexes or archives.

WITHDRAWN: Exosomes derived from BDNF-expressing 293T attenuate ischemic retinal injury in vitro and in vivo


Figure 6. Caveolin-1-mediated endocytosis of 293T-Exo was inhibited by MBCD. (A) Pretreatment of MBCD in R28 cells inhibited the endocytosis of 293T-Exo, as determined by the fluorescence assay. The nuclei were stained with DAPI (blue), the cytoskeleton was stained with tubulin (red), and 293T-Exo was stained with fluorescent-tag (green). Scale bar = 20 μm. (B) Efficacy of endocytosis of 293T-Exo by R28 cells was reversed due to increasing doses of MBCD. Data are presented as mean ± SD. *P < 0.05, **P < 0.01.